Aortic aneurysm: pathophysiology and therapeutic options
Authors:
Open Access
Abstract
Aortic aneurysm (AA) is an aortic disease with a high mortality rate, and other than surgery no effective preventive or therapeutic treatment have been developed. The renin–angiotensin system (RAS) is an important endocrine system that regulates vascular health. The ACE2/Ang‐(1–7)/MasR axis can antagonize the adverse effects of the activation of the ACE/Ang II/AT1R axis on vascular dysfunction, atherosclerosis, and the development of aneurysms, thus providing an important therapeutic target for the prevention and treatment of AA. However, products targeting the Ang‐(1–7)/MasR pathway still lack clinical validation. This review will outline the epidemiology of AA, including thoracic, abdominal, and thoracoabdominal AA, as well as current diagnostic and treatment strategies. Due to the highest incidence and most extensive research on abdominal AA (AAA), we will focus on AAA to explain the role of the RAS in its development, the protective function of Ang‐(1–7)/MasR, and the mechanisms involved. We will also describe the roles of agonists and antagonists, suggest improvements in engineering and drug delivery, and provide evidence for Ang‐(1–7)/MasR's clinical potential, discussing risks and solutions for clinical use. This study will enhance our understanding of AA and offer new possibilities and promising targets for therapeutic intervention.Keywords
This publication has 271 references indexed in Scilit:
- Effect of Angiotensin-(1-7) and Bradykinin in Patients With Heart Failure Treated With an ACE InhibitorHypertension, 1999
- Mas Oncogene Signaling and Transformation Require the Small GTP-Binding Protein RacMolecular and Cellular Biology, 1998
- Aneurysms of the Abdominal Aorta in Older AdultsAmerican Journal of Epidemiology, 1995
- Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humansAmerican Journal of Physiology-Endocrinology and Metabolism, 1994
- Aging and Human Hormonal and Pressor Responsiveness to Angiotensin II Infusion With Simultaneous Measurement of Exogenous and Endogenous Angiotensin IIAmerican Journal of Hypertension, 1993
- Effects of Aging and Hypertension on Plasma Angiotensin II and Platelet Angiotensin II Receptor DensityAmerican Journal of Hypertension, 1992
- Analysis of Angiotensin II Binding to Human Platelets: Differences in Young and Old SubjectsJournal of Gerontology, 1990
- Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain.Proceedings of the National Academy of Sciences, 1988
- Human ros1 and mas1 oncogenes located in regions of chromosome 6 associated with tumor-specific rearrangements.1987
- Role of hypertension in atherosclerosis and cardiovascular diseaseThe American Journal of Cardiology, 1976